This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C. Alkhalil , F. Tanvir , B. Alkhalil and D. T. Lowenthal 2004. Treatment of sexual disinhibition in dementia: case reports and review of the literature. American Journal of Therapeutics, 11, 231–235.
J. S. Aulakh , J. W. Hawkins , H. S. Athwal , J. I. Sheikh , J. Yesavage and J. R. Tinklenberg 2005. Tolerability and effectiveness of lamotrigine in complex elderly patients. Journal of Geriatric Psychiatry and Neurology, 18, 8–11.
R. F. Coen , G. R. Swanwick , C. A. O'Boyle and D. Coakley 1997. Behaviour disturbance and other predictors of carer burden in Alzheimer's disease. International Journal of Geriatric Psychiatry, 12, 331–336.
D. Cohen 1993. Psychopathology associated with Alzheimer's disease and related disorders. Journal of Gerontology, 48, M255–260.
J. L. Cummings and C. Back 1998. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. American Journal of Geriatric Psychiatry, 6, S64–78.
O. A. De Leon 2004. Treatment of psychotic symptoms with lamotrigine in Alzheimer's disease. Journal of Clinical Psychopharmacology, 24, 232–233.
A. Fitton and K. L. Goa 1995. Lamotrigine. an update of its pharmacology and therapeutic use in epilepsy. Drugs, 50, 691–713.
N. Freymann , R. Michael , R. Dodel and F. Jessen 2005. Successful treatment of sexual disinhibition in dementia with carbamazepine – a case report. Pharmacopsychiatry, 38, 144–145.
J. W. Hawkins , J. R. Tinklenberg , J. I. Sheikh , C. E. Peyser and J. A. Yesavage 2000. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. American Journal of Geriatric Psychiatry, 8, 221–225.
N. Herrmann , K. Lanctot and M. Myszak 2000. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia. Journal of Clinical Psychopharmacology, 20, 90–93.
N. Herrmann , K. L. Lanctot , L. S. Rothenburg and G. Eryavec 2007. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 23, 116–119.
C. Holmes 2001. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. Journal of Neurology, Neurosurgery and Psychiatry, 71, 777–779.
B. C. Jost and G. T. Grossberg 1996. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 1078–1081.
J. W. Kasckow , S. L. McElroy , R. L. Cameron , L. L. Mahler and S. J. Fudala 1997. A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the BEHAVE-AD and CGI rating scales. Current Therapeutic Research, Clinical and Experimental, 58, 981–989.
M. N. Kozman , J. Wattis and S. Curran 2006. Pharmacological management of behavioural and psychological disturbance in dementia. Human Psychopharmacology, 21, 1–12.
A. Lanari , F. Amenta , G. Silvestrelli , D. Tomassoni and L. Parnetti 2006. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mechanisms of Ageing and Development, 127, 158–165.
B. Lawlor 2002. Managing behavioural and psychological symptoms in dementia. British Journal of Psychiatry, 181, 463–465.
C. G. Lyketsos , M. Steinberg , J. T. Tschanz , M. C. Norton , D. C. Steffens and J. C. Breitner 2000. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry, 157, 708–714.
J. M. Meinhold , L.M. Blake , L. J. Mini , J. A. Welge , M. Schwiers and A. Hughes 2005. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia. Drugs & Aging, 22, 615–626.
M. Mendez and G. Lim 2003. Seizures in elderly patients with dementia: epidemiology and management. Drugs & Aging, 20, 791–803.
L. J. Miller 2001. Gabapentin for treatment of behavioral and psychological symptoms of dementia. Annals of Pharmacotherapy, 35, 427–431.
R. Moretti , P. Torre , R. M. Antonello , G. Cazzato and A. Bava 2003. Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation. Drugs & Aging, 20, 1035–1040.
D. L. Murman , Q. Chen , M. C. Powell , S.B. Kuo , C. J. Bradley and C. C. Colenda 2002. The incremental direct costs associated with behavioral symptoms in AD. Neurology, 59, 1721–1729.
M. Narayan and J. C. Nelson 1997. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. Journal of Clinical Psychiatry, 58, 351–354.
J. T. Olin , L. S. Fox , S. Pawluczyk , N. A. Taggart and L. S. Schneider 2001. A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with alzheimer disease. American Journal of Geriatric Psychiatry, 9, 400–405.
A. P. Porsteinsson , P. N. Tariot , R. Erb and S. Gaile 1997. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. American Journal of Geriatric Psychiatry, 5, 344–351.
A. P. Porsteinsson 2001. Placebo-controlled study of divalproex sodium for agitation in dementia. American Journal of Geriatric Psychiatry, 9, 58–66.
A. P. Porsteinsson 2003. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. American Journal of Geriatric Psychiatry, 11, 434–440.
F. Raudino , M. G. Mascalzi and A. Zagami 2004. Gabapentin and behavioral disorders in severe Alzheimer disease. Journal of Clinical Psychopharmacology, 24, 459–460.
W. M. Regan and S. M. Gordon 1997. Gabapentin for behavioral agitation in Alzheimer's disease. Journal of Clinical Psychopharmacology, 17, 59–60.
D. M. Roane , T. E. Feinberg , L. Meckler , C. R. Miner , A. Scicutella and R. N. Rosenthal 2000. Treatment of dementia-associated agitation with gabapentin. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 40–43.
P. Robert 2002. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine. Current Medical Research Opinion, 18, 156–171.
P. Rossi , M. Serrao and G. Pozzessere 2002. Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with Lewy bodies: case reports. European Neurology, 47, 56–57.
W. D. Sandborn , F. Bendfeldt and R. Hamdy 1995. Valproic acid for physically aggressive behavior in geriatric patients. American Journal of Geriatric Psychiatry, 3, 239–242.
K. M. Sink , K. F. Holden and K. Yaffe 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA, 293, 596–608.
R. C. Sival , P. M. J. Haffmans , P. P. van Gent and J. F. van Nieuwkerk 1994. The effects of sodium valproate on disturbed behavior in dementia. Journal of the American Geriatrics Society, 42, 906–907.
R. C. Sival , P. M. Haffmans , P. A. Jansen , S. A. Duursma and P. Eikelenboom 2002. Sodium valproate in the treatment of aggressive behavior in patients with dementia–a randomized placebo controlled clinical trial. International Journal of Geriatric Psychiatry, 17, 579–585.
R. C. Sival , H. J. Duivenvoorden , P. A. F. Jansen , J. Haffmans , S. A. Duursma and P. Eikelenboom 2004. Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study. International Journal of Geriatric Psychiatry, 19, 305–312.
Y. Stern 1994. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology, 44, 2300–2307.
Y. Stern , R. Mayeux , M. Sano , W. A. Hauser and T. Bush 1987. Predictors of disease course in patients with probable Alzheimer's disease. Neurology, 37, 1649–1653.
P. N. Tariot 2001. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Current Therapeutic Research – Clinical and Experimental, 62, 51–67.
P. N. Tariot . and Alzheimer's Disease Cooperative Study2005. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. American Journal of Geriatric Psychiatry, 13, 942–949.
H. S. White , S. D. Brown , J. H. Woodhead , G. A. Skeen and H. H. Wolf 2000. Topiramate modulates gaba-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia, 41 (Suppl. 1), S17–S20.
K. N. Chengappa 1999. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disorders, 1, 42–53.
C. Cooney A. Mortimer , A. Smith , K. Newton and M. Wrigley 1996. Carbamazepine use in aggressive behavior associated with senile dementia. International Journal of Geriatric Psychiatry, 11, 901–905.
J. F. Patterson 1988. A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. Journal of Geriatric Psychiatry and Neurology, 1, 21–23.
P. N. Tariot 1998. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. American Journal of Psychiatry, 155, 54–61.